Entities / Company
Precigen, Inc.
company in Blacksburg, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 23
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Precigen, Inc. listed on the Nasdaq stock exchange and filed disclosures with the SEC on August 25, 2026.Some support1 report
-
Precigen, Inc. traded on the Nasdaq stock exchange and filed required disclosures with the SEC on August 3, 2026.Some support2 reports
-
Precigen, Inc stock traded on Nasdaq and disclosed filings with the SEC on July 1, 2026.Some support2 reports
Gone quiet
No new reports in 90+ days-
Cantor Fitzgerald reaffirmed an overweight rating on June 26, 2026.Some support4 reports
-
Precigen, Inc received FDA approval for its therapy and utilizes LinkedIn for company presence, with Jennifer Kim associated with Cantor.Some support1 report
-
Precigen, Inc. received non-dilutive financing from Pharmakon Advisors, LP for its novel immunotherapy candidate, PAPZIMEOS.Some support2 reports1 development inside
-
The FDA granted approval for Papzimeos, a drug developed by Precigen, Inc.Well supported4 reports
-
Precigen, Inc. raised its stock price target following news of drug approval.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Precigen, Inc this week
News at the entities that move Precigen, Inc most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Precigen, Inc
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Precigen, Inc
-
Citigroup Mentioned togetherCitigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Moves Precigen, Inc
-
Nasdaq Shared contextApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Precigen, Inc
Connections
The 4 strongest of 23, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SEC Structural
Precigen, Inc is subject to regulatory oversight and filing requirements mandated by the SEC.
-
FDA Structural
The FDA formally regulates Precigen, granting priority review and final approval for its pharmaceutical therapies.
-
Citigroup Mentioned together
Citigroup provides research reports and rating recommendations regarding Precigen, Inc.
-
Nasdaq Shared context
Precigen, Inc's stock is listed and traded on the Nasdaq exchange.
History
Events by the month they beganAugust 2026
2 eventsJuly 2026
1 eventJune 2026
5 events- Cantor Fitzgerald reaffirmed an overweight rating on June 26, 2026.
- Precigen, Inc received FDA approval for its therapy and utilizes LinkedIn for company presence, with Jennifer Kim associated with Cantor.
- Precigen, Inc. received non-dilutive financing from Pharmakon Advisors, LP for its novel immunotherapy candidate, PAPZIMEOS.
- The FDA granted approval for Papzimeos, a drug developed by Precigen, Inc.
- Precigen, Inc. raised its stock price target following news of drug approval.